Copyright Reports & Markets. All rights reserved.

Global Alzheimer's Disease (AD) Blood-based Detection Kits Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Amyloid Beta (Aβ) Detection Kits
    • 1.3.3 Tau Protein Detection Kits
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Medical
    • 1.4.3 Research
  • 1.5 Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Size & Forecast
    • 1.5.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity (2019-2030)
    • 1.5.3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Roche Diagnostics
    • 2.1.1 Roche Diagnostics Details
    • 2.1.2 Roche Diagnostics Major Business
    • 2.1.3 Roche Diagnostics Alzheimer's Disease (AD) Blood-based Detection Kits Product and Services
    • 2.1.4 Roche Diagnostics Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Roche Diagnostics Recent Developments/Updates
  • 2.2 Fujirebio
    • 2.2.1 Fujirebio Details
    • 2.2.2 Fujirebio Major Business
    • 2.2.3 Fujirebio Alzheimer's Disease (AD) Blood-based Detection Kits Product and Services
    • 2.2.4 Fujirebio Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Fujirebio Recent Developments/Updates
  • 2.3 Quanterix
    • 2.3.1 Quanterix Details
    • 2.3.2 Quanterix Major Business
    • 2.3.3 Quanterix Alzheimer's Disease (AD) Blood-based Detection Kits Product and Services
    • 2.3.4 Quanterix Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Quanterix Recent Developments/Updates
  • 2.4 Revvity
    • 2.4.1 Revvity Details
    • 2.4.2 Revvity Major Business
    • 2.4.3 Revvity Alzheimer's Disease (AD) Blood-based Detection Kits Product and Services
    • 2.4.4 Revvity Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Revvity Recent Developments/Updates
  • 2.5 People Bio
    • 2.5.1 People Bio Details
    • 2.5.2 People Bio Major Business
    • 2.5.3 People Bio Alzheimer's Disease (AD) Blood-based Detection Kits Product and Services
    • 2.5.4 People Bio Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 People Bio Recent Developments/Updates
  • 2.6 Easund Bio-tech and Pharmakea
    • 2.6.1 Easund Bio-tech and Pharmakea Details
    • 2.6.2 Easund Bio-tech and Pharmakea Major Business
    • 2.6.3 Easund Bio-tech and Pharmakea Alzheimer's Disease (AD) Blood-based Detection Kits Product and Services
    • 2.6.4 Easund Bio-tech and Pharmakea Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Easund Bio-tech and Pharmakea Recent Developments/Updates
  • 2.7 MagQu
    • 2.7.1 MagQu Details
    • 2.7.2 MagQu Major Business
    • 2.7.3 MagQu Alzheimer's Disease (AD) Blood-based Detection Kits Product and Services
    • 2.7.4 MagQu Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 MagQu Recent Developments/Updates
  • 2.8 Solgent
    • 2.8.1 Solgent Details
    • 2.8.2 Solgent Major Business
    • 2.8.3 Solgent Alzheimer's Disease (AD) Blood-based Detection Kits Product and Services
    • 2.8.4 Solgent Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Solgent Recent Developments/Updates
  • 2.9 Sysmex
    • 2.9.1 Sysmex Details
    • 2.9.2 Sysmex Major Business
    • 2.9.3 Sysmex Alzheimer's Disease (AD) Blood-based Detection Kits Product and Services
    • 2.9.4 Sysmex Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Sysmex Recent Developments/Updates
  • 2.10 Fujifilm
    • 2.10.1 Fujifilm Details
    • 2.10.2 Fujifilm Major Business
    • 2.10.3 Fujifilm Alzheimer's Disease (AD) Blood-based Detection Kits Product and Services
    • 2.10.4 Fujifilm Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Fujifilm Recent Developments/Updates
  • 2.11 Immuno-Biological Laboratories
    • 2.11.1 Immuno-Biological Laboratories Details
    • 2.11.2 Immuno-Biological Laboratories Major Business
    • 2.11.3 Immuno-Biological Laboratories Alzheimer's Disease (AD) Blood-based Detection Kits Product and Services
    • 2.11.4 Immuno-Biological Laboratories Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Immuno-Biological Laboratories Recent Developments/Updates
  • 2.12 Shenzhen Anqun Bioengineering
    • 2.12.1 Shenzhen Anqun Bioengineering Details
    • 2.12.2 Shenzhen Anqun Bioengineering Major Business
    • 2.12.3 Shenzhen Anqun Bioengineering Alzheimer's Disease (AD) Blood-based Detection Kits Product and Services
    • 2.12.4 Shenzhen Anqun Bioengineering Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Shenzhen Anqun Bioengineering Recent Developments/Updates
  • 2.13 Amoneta Diagnostics
    • 2.13.1 Amoneta Diagnostics Details
    • 2.13.2 Amoneta Diagnostics Major Business
    • 2.13.3 Amoneta Diagnostics Alzheimer's Disease (AD) Blood-based Detection Kits Product and Services
    • 2.13.4 Amoneta Diagnostics Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Amoneta Diagnostics Recent Developments/Updates

3 Competitive Environment: Alzheimer's Disease (AD) Blood-based Detection Kits by Manufacturer

  • 3.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Manufacturer (2019-2024)
  • 3.3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Alzheimer's Disease (AD) Blood-based Detection Kits by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Alzheimer's Disease (AD) Blood-based Detection Kits Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Alzheimer's Disease (AD) Blood-based Detection Kits Manufacturer Market Share in 2023
  • 3.5 Alzheimer's Disease (AD) Blood-based Detection Kits Market: Overall Company Footprint Analysis
    • 3.5.1 Alzheimer's Disease (AD) Blood-based Detection Kits Market: Region Footprint
    • 3.5.2 Alzheimer's Disease (AD) Blood-based Detection Kits Market: Company Product Type Footprint
    • 3.5.3 Alzheimer's Disease (AD) Blood-based Detection Kits Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Size by Region
    • 4.1.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value by Region (2019-2030)
    • 4.1.3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Average Price by Region (2019-2030)
  • 4.2 North America Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value (2019-2030)
  • 4.3 Europe Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value (2019-2030)
  • 4.5 South America Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Type (2019-2030)
  • 5.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value by Type (2019-2030)
  • 5.3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Application (2019-2030)
  • 6.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value by Application (2019-2030)
  • 6.3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Type (2019-2030)
  • 7.2 North America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Application (2019-2030)
  • 7.3 North America Alzheimer's Disease (AD) Blood-based Detection Kits Market Size by Country
    • 7.3.1 North America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Type (2019-2030)
  • 8.2 Europe Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Application (2019-2030)
  • 8.3 Europe Alzheimer's Disease (AD) Blood-based Detection Kits Market Size by Country
    • 8.3.1 Europe Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Market Size by Region
    • 9.3.1 Asia-Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Type (2019-2030)
  • 10.2 South America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Application (2019-2030)
  • 10.3 South America Alzheimer's Disease (AD) Blood-based Detection Kits Market Size by Country
    • 10.3.1 South America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Alzheimer's Disease (AD) Blood-based Detection Kits Market Size by Country
    • 11.3.1 Middle East & Africa Alzheimer's Disease (AD) Blood-based Detection Kits Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Alzheimer's Disease (AD) Blood-based Detection Kits Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Alzheimer's Disease (AD) Blood-based Detection Kits Market Drivers
  • 12.2 Alzheimer's Disease (AD) Blood-based Detection Kits Market Restraints
  • 12.3 Alzheimer's Disease (AD) Blood-based Detection Kits Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Alzheimer's Disease (AD) Blood-based Detection Kits and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Alzheimer's Disease (AD) Blood-based Detection Kits
  • 13.3 Alzheimer's Disease (AD) Blood-based Detection Kits Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Alzheimer's Disease (AD) Blood-based Detection Kits Typical Distributors
  • 14.3 Alzheimer's Disease (AD) Blood-based Detection Kits Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Alzheimer's Disease (AD) blood-based detection kits are diagnostic tools designed to detect biomarkers associated with Alzheimer's disease in blood samples. These kits offer a non-invasive and potentially cost-effective method for early detection and monitoring of Alzheimer's disease. Several types of blood-based detection kits for Alzheimer's disease are being developed and studied, each targeting specific biomarkers or molecular signatures associated with the disease.
    According to our (Global Info Research) latest study, the global Alzheimer's Disease (AD) Blood-based Detection Kits market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Alzheimer's Disease (AD) Blood-based Detection Kits market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Alzheimer's Disease (AD) Blood-based Detection Kits market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Alzheimer's Disease (AD) Blood-based Detection Kits market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Alzheimer's Disease (AD) Blood-based Detection Kits market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Alzheimer's Disease (AD) Blood-based Detection Kits market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Alzheimer's Disease (AD) Blood-based Detection Kits
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Alzheimer's Disease (AD) Blood-based Detection Kits market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Diagnostics, Fujirebio, Quanterix, Revvity, People Bio, Easund Bio-tech and Pharmakea, MagQu, Solgent, Sysmex, Fujifilm, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Alzheimer's Disease (AD) Blood-based Detection Kits market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Amyloid Beta (Aβ) Detection Kits
    Tau Protein Detection Kits
    Others
    Market segment by Application
    Medical
    Research
    Major players covered
    Roche Diagnostics
    Fujirebio
    Quanterix
    Revvity
    People Bio
    Easund Bio-tech and Pharmakea
    MagQu
    Solgent
    Sysmex
    Fujifilm
    Immuno-Biological Laboratories
    Shenzhen Anqun Bioengineering
    Amoneta Diagnostics
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Alzheimer's Disease (AD) Blood-based Detection Kits product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Alzheimer's Disease (AD) Blood-based Detection Kits, with price, sales quantity, revenue, and global market share of Alzheimer's Disease (AD) Blood-based Detection Kits from 2019 to 2024.
    Chapter 3, the Alzheimer's Disease (AD) Blood-based Detection Kits competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Alzheimer's Disease (AD) Blood-based Detection Kits breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Alzheimer's Disease (AD) Blood-based Detection Kits market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Alzheimer's Disease (AD) Blood-based Detection Kits.
    Chapter 14 and 15, to describe Alzheimer's Disease (AD) Blood-based Detection Kits sales channel, distributors, customers, research findings and conclusion.

    Buy now